Back to Journals » International Journal of Chronic Obstructive Pulmonary Disease » Volume 9 » Issue 1

Efficacy and safety of olodaterol once daily delivered via Respimat® in patients with GOLD 2–4 COPD: results from two replicate 48-week studies

Total article views   HTML views PDF downloads Totals
20,007 Dovepress* 16,380+ 2,803 19,183
PubMed Central* 3,627 1,460 5,087
Totals 20,007 4,263 24,270
*Since 16 June 2014
+Since July 2016
Total mentioned Facebook Delicious Reddit Twitter Others
6 0 0 0 1 5

View citations on PubMed Central and Google Scholar